{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:38:46Z","timestamp":1791175126107,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1124\/jpet.104.071886","type":"journal-article","created":{"date-parts":[[2004,11,19]],"date-time":"2004-11-19T02:03:24Z","timestamp":1100829804000},"page":"929-938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Evaluation of Second Generation Amiloride Analogs as Therapy for Cystic Fibrosis Lung Disease"],"prefix":"10.1016","volume":"311","author":[{"given":"Andrew J.","family":"Hirsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan R.","family":"Sabater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andra","family":"Zamurs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick T.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Paradiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Boucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.104.071886_bib1","doi-asserted-by":"crossref","unstructured":"Adler KB, Wooten O, and Dulfano MJ (1973) Mammalian respiratory mucociliary clearance. Arch Environ Health 27: 364\u2013369.","DOI":"10.1080\/00039896.1973.10666403"},{"key":"10.1124\/jpet.104.071886_bib2","doi-asserted-by":"crossref","unstructured":"App EM, King M, Helfesrieder R, Kohler D, and Matthys H (1990) Acute and long-term amiloride inhalation in cystic fibrosis lung disease: a rational approach to cystic fibrosis therapy. Am Rev Respir Dis 141: 605\u2013612.","DOI":"10.1164\/ajrccm\/141.3.605"},{"key":"10.1124\/jpet.104.071886_bib3","doi-asserted-by":"crossref","unstructured":"Blank U, Ruckes C, Clauss W, Hofmann T, Lindemann H, Munker G, and Weber W (1997) Cystic fibrosis and non-cystic-fibrosis human nasal epithelium show analogous Na+ absorption and reversible block by phenamil. Pflugers Arch 434: 19\u201324.","DOI":"10.1007\/s004240050358"},{"key":"10.1124\/jpet.104.071886_bib4","doi-asserted-by":"crossref","unstructured":"Boucher RC (1994) Human airway ion transport: I. Am J Respir Crit Care Med 150: 271\u2013281.","DOI":"10.1164\/ajrccm.150.1.8025763"},{"key":"10.1124\/jpet.104.071886_bib5","doi-asserted-by":"crossref","unstructured":"Bowler IM, Kelman B, Worthington D, Littlewood JM, Watson A, Conway SP, Smye SW, James SL, and Sheldon TA (1995) Nebulised amiloride in respiratory exacerbations of cystic fibrosis: a randomised controlled trial. Arch Dis Child 73: 427\u2013430.","DOI":"10.1136\/adc.73.5.427"},{"key":"10.1124\/jpet.104.071886_bib6","doi-asserted-by":"crossref","unstructured":"Burleigh DE (2003) Involvement of inwardly rectifying K+ channels in secretory responses of human ileal mucosa. J Pharm Pharmacol 55: 527\u2013531.","DOI":"10.1211\/0022357021008"},{"key":"10.1124\/jpet.104.071886_bib7","unstructured":"Bush A (2000) Primary ciliary dyskinesia. Acta Otorhinolaryngol Belg 54: 317\u2013324."},{"key":"10.1124\/jpet.104.071886_bib8","doi-asserted-by":"crossref","unstructured":"Gatzy JT (1975) Ion transport across the excised bullfrog lung. Am J Physiol 228: 1162\u20131171.","DOI":"10.1152\/ajplegacy.1975.228.4.1162"},{"key":"10.1124\/jpet.104.071886_bib9","doi-asserted-by":"crossref","unstructured":"Graham A, Hasani A, Alton EW, Martin GP, Marriott C, Hodson ME, Clarke SW, and Geddes DM (1993) No added benefit from nebulized amiloride in patients with cystic fibrosis. Eur Respir J 6: 1243\u20131248.","DOI":"10.1183\/09031936.93.06091243"},{"key":"10.1124\/jpet.104.071886_bib10","doi-asserted-by":"crossref","unstructured":"Grubb BR, Schiretz FR, and Boucher RC (1997) Volume transport across tracheal and bronchial airway epithelia in a tubular culture system. Am J Physiol 273: C21\u2013C29.","DOI":"10.1152\/ajpcell.1997.273.1.C21"},{"key":"10.1124\/jpet.104.071886_bib11","doi-asserted-by":"crossref","unstructured":"Guia A, Chau T, Bose D, and Bose R (1996) Mechanism of cardiac inotropy by phenamil and epithelial sodium channel blocker. J Pharmacol Exp Ther 277: 163\u2013173.","DOI":"10.1016\/S0022-3565(25)12803-6"},{"key":"10.1124\/jpet.104.071886_bib12","doi-asserted-by":"crossref","unstructured":"Guia A, Leblanc N, and Bose R (1995) Effects of phenamil on potassium and calcium channels of guinea pig ventricular myocytes. J Pharmacol Exp Ther 274: 649\u2013656.","DOI":"10.1016\/S0022-3565(25)10572-7"},{"key":"10.1124\/jpet.104.071886_bib13","doi-asserted-by":"crossref","unstructured":"Hirsh AJ (2002) Altering airway surface liquid volume: inhalation therapy with amiloride and hyperosmotic agents. Adv Drug Deliv Rev 54: 1445\u20131462.","DOI":"10.1016\/S0169-409X(02)00161-8"},{"key":"10.1124\/jpet.104.071886_bib14","doi-asserted-by":"crossref","unstructured":"Hofmann T, Senier I, Bittner P, Huls G, Schwandt HJ, and Lindemann H (1997) Aerosolized amiloride: dose effect on nasal bioelectric properties, pharmacokinetics and effect on sputum expectoration in patients with cystic fibrosis. J Aerosol Med 10: 147\u2013158.","DOI":"10.1089\/jam.1997.10.147"},{"key":"10.1124\/jpet.104.071886_bib15","doi-asserted-by":"crossref","unstructured":"Hofmann T, Stutts MJ, Ziersch A, Ruckes C, Weber WM, Knowles MR, Lindemann H, and Boucher RC (1998) Effects of topically delivered benzamil and amiloride on nasal potential difference in cystic fibrosis. Am J Respir Crit Care Med 157: 1844\u20131849.","DOI":"10.1164\/ajrccm.157.6.9709043"},{"key":"10.1124\/jpet.104.071886_bib16","doi-asserted-by":"crossref","unstructured":"Horisberger JD (1998) Amiloride-sensitive Na channels. Curr Opin Cell Biol 10: 443\u2013449.","DOI":"10.1016\/S0955-0674(98)80056-2"},{"key":"10.1124\/jpet.104.071886_bib17","doi-asserted-by":"crossref","unstructured":"Houtmeyers E, Gosselink R, Gayan-Ramirez G, and Decramer M (1999) Regulation of mucociliary clearance in health and disease. Eur Respir J 13: 1177\u20131188.","DOI":"10.1034\/j.1399-3003.1999.13e39.x"},{"key":"10.1124\/jpet.104.071886_bib18","doi-asserted-by":"crossref","unstructured":"Kerem E, Bistritzer T, Hanukoglu A, Hofmann T, Zhou Z, Bennett W, MacLaughlin E, Barker P, Nash M, Quittell L, et al. (1999) Pulmonary epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism. N Engl J Med 341: 156\u2013162.","DOI":"10.1056\/NEJM199907153410304"},{"key":"10.1124\/jpet.104.071886_bib19","doi-asserted-by":"crossref","unstructured":"Kleyman TR and Cragoe EJ Jr (1988) Amiloride and its analogs as tools in the study of ion transport. J Membr Biol 105: 1\u201321.","DOI":"10.1007\/BF01871102"},{"key":"10.1124\/jpet.104.071886_bib20","doi-asserted-by":"crossref","unstructured":"Knowles MR and Boucher RC (2002) Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Investig 109: 571\u2013577.","DOI":"10.1172\/JCI200215217"},{"key":"10.1124\/jpet.104.071886_bib21","doi-asserted-by":"crossref","unstructured":"Knowles MR, Church NL, Waltner WE, Yankaskas JR, Gilligan P, King M, Edwards LJ, Helms RW, and Boucher RC (1990) A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis. N Engl J Med 322: 1189\u20131194.","DOI":"10.1056\/NEJM199004263221704"},{"key":"10.1124\/jpet.104.071886_bib22","doi-asserted-by":"crossref","unstructured":"Knowles MR, Stutts MJ, Spock A, Fischer N, Gatzy JT, and Boucher RC (1983) Abnormal ion permeation through cystic fibrosis respiratory epithelium. Science (Wash DC) 221: 1067\u20131070.","DOI":"10.1126\/science.6308769"},{"key":"10.1124\/jpet.104.071886_bib23","unstructured":"Kohler D, App E, Schmitz-Schumann M, Wurtemberger G, and Matthys H (1986) Inhalation of amiloride improves the mucociliary and the cough clearance in patients with cystic fibroses. Eur J Respir Dis Suppl 146: 319\u2013326."},{"key":"10.1124\/jpet.104.071886_bib24","doi-asserted-by":"crossref","unstructured":"Mall M, Grubb BR, Harkema JR, O\u2019Neal WK, and Boucher RC (2004) Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice. Nat Med 10: 487\u2013493.","DOI":"10.1038\/nm1028"},{"key":"10.1124\/jpet.104.071886_bib25","doi-asserted-by":"crossref","unstructured":"Matsui H, Grubb BR, Tarran R, Randell SH, Gatzy JT, Davis CW, and Boucher RC (1998a) Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 95: 1005\u20131015.","DOI":"10.1016\/S0092-8674(00)81724-9"},{"key":"10.1124\/jpet.104.071886_bib26","doi-asserted-by":"crossref","unstructured":"Matsui H, Randell SH, Peretti SW, Davis CW, and Boucher RC (1998b) Coordinated clearance of periciliary liquid and mucus from airway surfaces. J Clin Investig 102: 1125\u20131131.","DOI":"10.1172\/JCI2687"},{"key":"10.1124\/jpet.104.071886_bib27","doi-asserted-by":"crossref","unstructured":"Mentz WM, Brown JB, Friedman M, Stutts MJ, Gatzy JT, and Boucher RC (1986) Deposition, clearance and effects of aerosolized amiloride in sheep airways. Am Rev Respir Dis 134: 938\u2013943.","DOI":"10.1164\/arrd.1986.134.5.938"},{"key":"10.1124\/jpet.104.071886_bib28","unstructured":"Min YG, Shin JS, Choi SH, Chi JG, and Yoon CJ (1995) Primary ciliary dyskinesia: ultrastructural defects and clinical features. Rhinology 33: 189\u2013193."},{"key":"10.1124\/jpet.104.071886_bib29","doi-asserted-by":"crossref","unstructured":"Noone PG, Regnis JA, Liu X, Brouwer KL, Robinson M, Edwards L, and Knowles MR (1997) Airway deposition and clearance and systemic pharmacokinetics of amiloride following aerosolization with an ultrasonic nebulizer to normal airways. Chest 112: 1283\u20131290.","DOI":"10.1378\/chest.112.5.1283"},{"key":"10.1124\/jpet.104.071886_bib30","doi-asserted-by":"crossref","unstructured":"Pons G, Marchand MC, d\u2019Athis P, Sauvage E, Foucard C, Chaumet-Riffaur P, Sautegeau A, Navarro J, Lenoir G, and Amiloride-AFLM Collaborative Study Group (2000) French multicenter randomized double-blind placebo-controlled trial on nebulized amiloride in cystic fibrosis patients. Pediatr Pulmonol 30: 25\u201331.","DOI":"10.1002\/1099-0496(200007)30:1<25::AID-PPUL5>3.0.CO;2-C"},{"key":"10.1124\/jpet.104.071886_bib31","doi-asserted-by":"crossref","unstructured":"Prince LS, Launspach JL, Geller DS, Lifton RP, Pratt JH, Zabner J, and Welsh MJ (1999) Absence of amiloride-sensitive sodium absorption in the airway of an infant with pseudohypoaldosteronism. J Pediatr 135: 786\u2013789.","DOI":"10.1016\/S0022-3476(99)70105-8"},{"key":"10.1124\/jpet.104.071886_bib32","doi-asserted-by":"crossref","unstructured":"Puchelle E, Bajolet O, and Abely M (2002) Airway mucus in cystic fibrosis. Paediatr Respir Rev 3: 115\u2013119.","DOI":"10.1016\/S1526-0550(02)00005-7"},{"key":"10.1124\/jpet.104.071886_bib33","doi-asserted-by":"crossref","unstructured":"Regnis JA, Zeman KL, Noone PG, Knowles MR, and Bennett WD (2000) Prolonged airway retention of insoluble particles in cystic fibrosis versus primary ciliary dyskinesia. Exp Lung Res 26: 149\u2013162.","DOI":"10.1080\/019021400269844"},{"key":"10.1124\/jpet.104.071886_bib34","doi-asserted-by":"crossref","unstructured":"Robinson M, Eberl S, Tomlinson C, Daviskas E, Regnis JA, Bailey DL, Torzillo PJ, Menache M, and Bye PT (2000) Regional mucociliary clearance in patients with cystic fibrosis. J Aerosol Med 13: 73\u201386.","DOI":"10.1089\/089426800418604"},{"key":"10.1124\/jpet.104.071886_bib35","doi-asserted-by":"crossref","unstructured":"Rodgers HC and Knox AJ (1999) The effect of topical benzamil and amiloride on nasal potential difference in cystic fibrosis. Eur Respir J 14: 693\u2013696.","DOI":"10.1034\/j.1399-3003.1999.14c32.x"},{"key":"10.1124\/jpet.104.071886_bib36","doi-asserted-by":"crossref","unstructured":"Sabater JR, Mao YM, Shaffer C, James MK, O\u2019Riordan TG, and Abraham WM (1999) Aerosolization of P2Y(2)-receptor agonists enhances mucociliary clearance in sheep. J Appl Physiol 87: 2191\u20132196.","DOI":"10.1152\/jappl.1999.87.6.2191"},{"key":"10.1124\/jpet.104.071886_bib37","doi-asserted-by":"crossref","unstructured":"Sood N, Bennett WD, Zeman K, Brown J, Foy C, Boucher RC, and Knowles MR (2003) Increasing concentration of inhaled saline with or without amiloride: effect on mucociliary clearance in normal subjects. Am J Respir Crit Care Med 167: 158\u2013163.","DOI":"10.1164\/rccm.200204-293OC"},{"key":"10.1124\/jpet.104.071886_bib38","doi-asserted-by":"crossref","unstructured":"Stutts MJ, Canessa CM, Olsen JC, Hamrick M, Cohn JA, Rossier BC, and Boucher RC (1995) CFTR as a cAMP-dependent regulator of sodium channels. Science (Wash DC) 269: 847\u2013850.","DOI":"10.1126\/science.7543698"},{"key":"10.1124\/jpet.104.071886_bib39","doi-asserted-by":"crossref","unstructured":"Talbot AR, Herr TM, and Parsons DS (1997) Mucociliary clearance and buffered hypertonic saline solution. Laryngoscope 107: 500\u2013503.","DOI":"10.1097\/00005537-199704000-00013"},{"key":"10.1124\/jpet.104.071886_bib40","doi-asserted-by":"crossref","unstructured":"Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, Sai Y, and Tsuji A (1998) Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 273: 20378\u201320382.","DOI":"10.1074\/jbc.273.32.20378"},{"key":"10.1124\/jpet.104.071886_bib41","doi-asserted-by":"crossref","unstructured":"Tarran R, Grubb BR, Parsons D, Picher M, Hirsh AJ, Davis CW, and Boucher RC (2001) The CF salt controversy: in vivo observations and therapeutic approaches. Mol Cell 8: 149\u2013158.","DOI":"10.1016\/S1097-2765(01)00286-6"},{"key":"10.1124\/jpet.104.071886_bib42","doi-asserted-by":"crossref","unstructured":"Wanner A, Salathe M, and O\u2019Riordan TG (1996) Mucociliary clearance in the airways. Am J Respir Crit Care Med 154: 1868\u20131902.","DOI":"10.1164\/ajrccm.154.6.8970383"},{"key":"10.1124\/jpet.104.071886_bib43","doi-asserted-by":"crossref","unstructured":"Wright SH and Wunz TM (1989) Amiloride transport in rabbit renal brush-border membrane vesicles. Am J Physiol 256: F462\u2013F468.","DOI":"10.1152\/ajprenal.1989.256.3.F462"},{"key":"10.1124\/jpet.104.071886_bib44","doi-asserted-by":"crossref","unstructured":"Wu X, Prasad PD, Leibach FH, and Ganapathy V (1998) cDNA sequence, transport function and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 246: 589\u2013595.","DOI":"10.1006\/bbrc.1998.8669"},{"key":"10.1124\/jpet.104.071886_bib45","doi-asserted-by":"crossref","unstructured":"Yerxa BR, Sabater JR, Davis CW, Stutts MJ, Lang-Furr M, Picher M, Jones AC, Cowlen M, Dougherty R, Boyer J, et al. (2002) Pharmacology of INS37217 [P(1)-(uridine 5\u2032)-P(4)-(2\u2032-deoxycytidine 5\u2032)tetraphosphate, tetrasodium salt], a next-generation P2Y(2) receptor agonist for the treatment of cystic fibrosis. J Pharmacol Exp Ther 302: 871\u2013880.","DOI":"10.1124\/jpet.102.035485"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652431674X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002235652431674X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.104.071886","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:05:35Z","timestamp":1739999135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002235652431674X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S002235652431674X"],"URL":"https:\/\/doi.org\/10.1124\/jpet.104.071886","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Second Generation Amiloride Analogs as Therapy for Cystic Fibrosis Lung Disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.104.071886","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}